Patent · US Expired

11-benzaldoxime-17.beta.-methoxy-17.alpha.-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds

US5576310A · kind A · utility

12Cited by
7References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 20, 1994
Grant dateNov 19, 1996
Priority date
Expiry dateSep 20, 2014

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J41/0083
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention relates to new 11-benzaldoxime-estra-diene derivatives of the general formula I ##STR1## wherein Z is --CO--CH.sub.3, --CO--O--C.sub.2 H.sub.5, --CO--NH-phenyl, --CO--NH--C.sub.2 H.sub.5, --CO--C.sub.2 H.sub.5, --CH.sub.3, or --CO-phenyl and their pharmaceutically acceptable salts, a method for their production, and pharmaceuticals containing such compounds. The compounds of the general formula I are produced by esterifying or etherizing a compound of the general formula II ##STR2## The compounds described show strong antigestagenic effects combined with reduced glucocorticoid activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.